CClinicalTrials.gg
CompletedNCT06296355Updated Oct 15, 2024

Impacts of Warning Labels on Ultra-Processed Foods

An interventional study of Health Warning Label and Identity Warning Label in Health Behavior and Diet, Healthy, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
4,000
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Purpose: The overall purpose of this study is to identify the impacts of an ultra-processed (UPF) health warning label and UPF identify warning label compared to a control label (i.e., a barcode).

Participants: \~4,000 US Latino adults of parental age (18-55 years), approximately 50% of whom will have limited English proficiency, recruited from a Latino-focused panel company.

Procedures: Participants will be randomly assigned to view food products with one of three label types: health warning labels, identity labels, or barcode control labels. Participants will be asked a series of questions about the products and the label they were assigned.

Read the detailed description

On the study platform (Qualtrics), participants will be randomly assigned to 1 of 3 arms with equal probability: a UPF health warning label, a UPF identity label, or a barcode control label. Participants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) displayed in random order, each with a label displayed on the front of package according to the participants' study arm. Participants will complete a 13-item online survey to assess each product as to a) whether the product is ultra-processed; b) perceptions of healthfulness; c) intentions to purchase the product.

02

Conditions studied

  • Health Behavior
  • Diet, Healthy

Keywords

  • front-of-package labels
  • ultra-processed food
  • food and beverage purchases
03

In context

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Identifying as Latino or Hispanic
  • Ages 18-55 years old
  • Currently resides in the United States

Exclusion criteria

Exclusion Criteria:

  • Not identifying as Latino or Hispanic
  • Less than 18 or greater than 55 years old
  • Not residing in the United States
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
4,000 participants (actual)

Study arms

  • Experimental
    Health Warning Label

    Participants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) each with a health warning label displayed on the front of package.

    Behavioral: Health Warning Label

  • Experimental
    Identity Warning Label

    Participants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) each with an identity warning label displayed on the front of package.

    Behavioral: Identity Warning Label

  • Other
    Barcode Label

    Participants will view four products (a fruit-flavored drink, pretzels, a yogurt, and a breakfast cereal) each with a barcode control label displayed on the front of package.

    Other: Barcode Label

Interventions

  • BehavioralHealth Warning Label

    Message displayed on warning label is: "WARNING: Consuming ultra-processed food and drinks can cause weight gain, which increases the risk of obesity and type 2 diabetes."

  • BehavioralIdentity Warning Label

    Message displayed on warning label is: "WARNING: Ultra-processed food".

  • OtherBarcode Label

    Barcode is displayed.

06

What researchers measure

Primary outcomes

  1. Identification of a product as ultra-processed

    Correct identification of a product as ultra-processed. Measured with the question, "Do you think this product is ultra-processed?" Response options are Yes, No, and I'm not sure.

    Time frame: Immediately after exposure to intervention, assessed during 1-time online study visit.

Secondary outcomes

  1. Perceived product healthfulness of ultra-processed products

    Measured with the question, "How good or bad for your health would it be to consume this product every day?" Likert responses are on a 1 to 5 scale, from "Very bad" (coded as 1) to "Very good" (coded as 5), with higher scores representing a higher perceived healthfulness.

    Time frame: Immediately after exposure to intervention, assessed during 1-time online study visit.

  2. Intentions to purchase ultra-processed products

    Measured with the question, "How likely would you be to purchase this product in the next week, if it were available?" Likert responses are on a 1 to 5 scale, from "Not at all likely" (coded as 1) to "Extremely likely" (coded as 5), with higher scores representing a higher intention to purchase ultra-processed products.

    Time frame: Immediately after exposure to intervention, assessed during 1-time online study visit.

  3. Perceived message effectiveness

    Measured with the question, "How much does this message discourage you from wanting to consume an ultra-processed food or drink?" Likert responses are on a 1 to 5 scale, from "Not at all" (coded as 1) to "Very much" (coded as 5), with higher scores representing a higher perceived message effectiveness.

    Time frame: Immediately after exposure to intervention, assessed during 1-time online study visit.

07

Study locations

1 site
  • UNC Carolina Population Center
    Chapel Hill, North Carolina 27516, United States
08

References and documents

Study documents

  • Statistical analysis plan · Apr 16, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — A deidentified dataset and the corresponding survey codebook will be shared beginning 9 months and continuing for 36 months after publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC. The study protocol, statistical analysis plan, and informed consent form will be published alongside as supplementary material.

Supporting information: Study protocol, Sap, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06296355
Lead sponsor
University of North Carolina, Chapel Hill
Collaborators
Robert Wood Johnson Foundation
Responsible party
Sponsor
First posted
Mar 6, 2024
Start date
Aug 9, 2024
Primary completion
Sep 11, 2024
Completion
Sep 11, 2024
Last update
Oct 15, 2024

Study contacts

Lindsey Smith Taillie, PhD
principal investigator · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion